The first smallpox treatment, being developed for the United States government in the case of a bioterrorism attack, could be available as early as August.
FDA approved a new indication for Exparel Bupivacaine Liposome injectable suspension (Exparel, Pacira) for use as a nerve block to produce post-surgical regional analgesia following shoulder surgery in adults.
FDA recently approved 3 major drugs to treat lung cancer, prostate cancer, and cystic fibrosis. Here are the top 3 new drug approvals.
A patient advocacy group is criticizing the hefty price tag of a new treatment for blindness.
FDA is taking its toughest stance yet on opioid-containing cough and cold medications for children.
FDA approved the first drug to treat certain patients with metastatic breast cancer who have a “BRCA” gene mutation.
Here are 3 of the top new drug approvals in late December and early January.
New blockbuster drugs to treat various conditions are expected to be among the top drugs to hit the marketplace in 2018. Here are 5 of the top new drugs in the pipeline for 2018, according to analysts.
Even though another biosimilar to infliximab (Remicade) was approved by FDA in mid-December, it likely won’t be marketed in the United States.
FDA okays the first short-acting insulin approved as a “follow-on” product.